A total of 50 healthy candidates and 150 patients with LC (50 SCLC, 50 LUAD, and 50 LUSC) were enrolled in the study to verify the diagnostic potential of FOXD3-AS1. Here, FOXD3 is linked to small cell lung carcinoma.